BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26776676)

  • 1. Laparoscopic Splenectomy for Secondary Cytoreduction in Ovarian Cancer Patients With Localized Spleen Recurrence: Feasibility and Technique.
    Gallotta V; Nero C; Lodoli C; Chiantera V; Pacelli F; Fagotti A; Costantini B; Scambia G
    J Minim Invasive Gynecol; 2016; 23(3):425-8. PubMed ID: 26776676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique.
    Macciò A; Sanna E; Lavra F; Chiappe G; Petrillo M; Madeddu C
    BMC Surg; 2021 Oct; 21(1):380. PubMed ID: 34711237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience.
    Gallotta V; Conte C; Giudice MT; Nero C; Vizzielli G; Gueli Alletti S; Cianci S; Lodoli C; Di Giorgio A; De Rose AM; Fagotti A; Scambia G; Ferrandina G
    J Minim Invasive Gynecol; 2018; 25(4):644-650. PubMed ID: 29081384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes.
    Fagotti A; Costantini B; Gallotta V; Cianci S; Ronsini C; Petrillo M; Pacciani M; Scambia G; Fanfani F
    J Minim Invasive Gynecol; 2015; 22(3):428-32. PubMed ID: 25461683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic Splenectomy as Quaternary Cytoreduction for Isolated Parenchymal Splenic Recurrence of Epitelial Tubo-Ovarian Cancer: Report of a Case and Literature Review.
    Sorbi F; Prosperi P; Villanucci A; Berti V; Sisti G; Fambrini M
    Gynecol Obstet Invest; 2015; 80(4):265-71. PubMed ID: 25677585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robotic-assisted laparoscopic splenectomy for recurrent ovarian cancer.
    Paterniti TA; Ahmad S; Holloway RW
    Int J Gynecol Cancer; 2020 Aug; 30(8):1189-1194. PubMed ID: 32624496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic splenectomy for secondary cytoreduction of ovarian cancer in a woman with localized splenic recurrence.
    Acosta-Torres S; Fader AN
    Gynecol Oncol; 2020 Mar; 156(3):744-745. PubMed ID: 31955860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic splenectomy for solitary splenic metastasis in a patient with ovarian cancer with a long disease-free interval: a case report.
    Yasuda K; Yoshimura T; Kitade H; Yanagida H; Hosaka N
    J Med Case Rep; 2018 May; 12(1):132. PubMed ID: 29759073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenectomy as Part of Cytoreductive Surgery in Recurrent Epithelial Ovarian Cancer.
    Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Sep; 35(9):5097-101. PubMed ID: 26254413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenectomy in recurrent epithelial ovarian cancer.
    Gemignani ML; Chi DS; Gurin CC; Curtin JP; Barakat RR
    Gynecol Oncol; 1999 Mar; 72(3):407-10. PubMed ID: 10053114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic Management of Ovarian Cancer Patients With Localized Carcinomatosis and Lymph Node Metastases: Results of a Retrospective Multi-institutional Series.
    Gallotta V; Ghezzi F; Vizza E; Fagotti A; Ceccaroni M; Fanfani F; Chiantera V; Ercoli A; Rossitto C; Conte C; Uccella S; Corrado G; Scambia G; Ferrandina G
    J Minim Invasive Gynecol; 2016; 23(4):590-6. PubMed ID: 26872630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy.
    Favero G; Macerox N; Pfiffer T; Köhler C; da Costa Miranda V; Estevez Diz Mdel P; Fukushima JT; Baracat EC; Carvalho JP
    Oncology; 2015; 89(3):159-66. PubMed ID: 25968072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer.
    Paik ES; Lee YY; Kim TJ; Choi CH; Lee JW; Kim BG; Bae DS
    J Gynecol Oncol; 2016 May; 27(3):e24. PubMed ID: 27029745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience.
    Gallotta V; Fagotti A; Fanfani F; Ferrandina G; Nero C; Costantini B; Gueli Alletti S; Chiantera V; Ercoli A; Scambia G
    Surg Endosc; 2014 Jun; 28(6):1808-15. PubMed ID: 24414460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic Debulking Surgery in the Management of Advanced Ovarian Cancer After Neoadjuvant Chemotherapy.
    Corrado G; Mancini E; Cutillo G; Baiocco E; Vici P; Sergi D; Patrizi L; Saltari M; Baffa A; Vizza E
    Int J Gynecol Cancer; 2015 Sep; 25(7):1253-7. PubMed ID: 26111273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: Perioperative and oncologic outcomes.
    Eriksson AGZ; Graul A; Yu MC; Halko A; Chi DS; Zivanovic O; Gardner GJ; Sonoda Y; Barakat RR; Abu-Rustum NR; Leitao MM
    Gynecol Oncol; 2017 Aug; 146(2):263-267. PubMed ID: 28527673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenectomy in patients with advanced or recurrent ovarian cancer: open and laparoscopic surgical techniques and clinical outcomes.
    Ramirez PT; Dos Reis R
    Gynecol Oncol; 2007 Feb; 104(2 Suppl 1):29-32. PubMed ID: 17175013
    [No Abstract]   [Full Text] [Related]  

  • 18. Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study.
    Gueli Alletti S; Bottoni C; Fanfani F; Gallotta V; Chiantera V; Costantini B; Cosentino F; Ercoli A; Scambia G; Fagotti A
    Am J Obstet Gynecol; 2016 Apr; 214(4):503.e1-503.e6. PubMed ID: 26529370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenectomy during secondary cytoreduction for ovarian cancer disease recurrence: surgical and survival data.
    Manci N; Bellati F; Muzii L; Calcagno M; Alon SA; Pernice M; Angioli R; Panici PB
    Ann Surg Oncol; 2006 Dec; 13(12):1717-23. PubMed ID: 16957965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic and hand-assisted laparoscopic splenectomy for recurrent and persistent ovarian cancer.
    Chi DS; Abu-Rustum NR; Sonoda Y; Im HB; Jhamb N; D'Angelica M; Rim M; Dupont J; Barakat RR
    Gynecol Oncol; 2006 May; 101(2):224-7. PubMed ID: 16337997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.